___

• Badawi N, Watson L, Petterson B, et al. What constitute cerebral palsy. Dev Med Child Neurol 1998; 40:520- 7.
• Graham H.K, Aoki K.R, Autti-Ramö I, Boyd R.N, Delgado M.R, Deborah J et all. Recommendation for the use of botulinum toxin type A in the management of cerebral palsy. Gait and Posture 11, 2000, 67-79.
• Dabney KW, Lipton GE, Miller F. Cerbral palsy. Curr Opin Pediatr 1997; 9:81-8.
• Cooper J, Majnemer A, Rosenblatt B, et al. The determination of sensory deficits in children with hemiplegic cerebral palsy. J Child Neurol 1995; 10:300- 9.
• Russman BS. Cerebral plasy. Current treatment options. Neurology 2000; 2:97-108.
• Anonymous. Surveillance of cerebral palsy in Europe (SSPE). Dev Med Child Neurol 2000; 42:816-24.
• Çil A, Aksoy M.C, Çeliker R. Serebral palsi tedavisinde botulinum toksini uygulamalarý. Hacettepe Týp Dergisi 2006; 37:43-48.
• Boyd R.N, Graham H.K. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerabral palsy. Eur J Neurol 1999;(Suppl.4):523-35.
• Sathyamurthy V, Dasgupta BR. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E. J Biol Chem 1985; 260:10461-6.
• Jankovic J, Hallet M, eds. Therapy with botulinum toxin. New York: Marcel Decker, 1994.
• Moore P, ed. Handbook of botulinum toxin treatment. Oxford: Blackwell Science, 1995.
• Carr LJ, Cosgrove AP, Gringrass P, et al. Position paper on the use of botulinum toxin in cerbral palsy. Arch Dis Child 1998; 79:271-3.
• Mathiowetz V, Federman S, Wiemer D. Box and block test of manual dexterity: norms for 6-19 year olds. Can J Occup Ther 1985;52:241-5
• Boyd R.N, Graham H.K. Botulinum toxin type A in the management of children with cerebral palsy: indications and outcome. Eur J Neurol 1997;4:S15- 22.
• Delgado MR. The use of botulinum toxin type A in children with cerebral palsy: a retrospective study. Eur J Neurol 1999; 6(Suppl 4):11-8.
• Bakheit AM, Severa S, Cosgrove A, et al. Safety profile of botulinum toxin (DYSPORT) in children with muscle spasticity. Dev Med Child Neurol 2001; 43:234-8.
• Corry I, Cosgrove A, Duffy C, McNeil S, Taylor T,Graham H. Botulinum toxin type A compared with stretching cast in the treatment of spastic equinus, a randomised prospective trial. J Pediatr Orthop 1998;18:304-11.